New paradigms in the mechanisms and management of glaucoma (Q35949074)

11 August 2017

1 reference

title

New paradigms in the mechanisms and management of glaucoma (English)

1 reference

11 August 2017

Quigley HA

1

1 reference

PubMed ID

15543179

11 August 2017

language of work or name

1 reference

1 December 2005

1 reference

11 August 2017

1 reference

11 August 2017

19

1 reference

11 August 2017

12

1 reference

11 August 2017

1241-1248

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.eye.6701746

11 August 2017

0 references

cites work

The definition and classification of glaucoma in prevalence surveys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Doyne Lecture. Glaucoma: facts and fancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Prevalence and predictors of open-angle glaucoma: results from the visual impairment project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Collaborative Normal Tension Glaucoma Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Number of people with glaucoma worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Glaucoma in China: how big is the problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Possible mechanisms of primary angle-closure and malignant glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

The Barbados Eye Study. Prevalence of open angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Estimating incidence from age-specific prevalence in glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Five-year incidence of open-angle glaucoma: the visual impairment project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Natural history of normal-tension glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Blindness in patients with treated open-angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Glaucoma screening. A cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Cost effectiveness of screening for primary open angle glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Community screening for eye disease by laypersons: the Hoffberger program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Long term results of glaucoma surgery among participants in an east African population survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Screening for primary angle closure in Mongolia: a randomised controlled trial to determine whether screening and prophylactic treatment will reduce the incidence of primary angle closure glaucoma in an east Asian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Topical timolol decreases plasma high-density lipoprotein cholesterol level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Optic disc rim area is related to disc size in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Race-, age-, gender-, and refractive error-related differences in the normal optic disc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Persistency with latanoprost or timolol in primary open-angle glaucoma suspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Patient noncompliance in the managed care setting. The case of medical therapy for glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

TUNEL-positive ganglion cells in human primary open-angle glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Alterations in elastin of the optic nerve head in human and experimental glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

TRAAK is a mammalian neuronal mechano-gated K+ channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine: the Friedenwald lecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

Estimating progression of visual field loss in glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

7 January 2021

The probability of blindness from open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

7 January 2021

A population-based evaluation of glaucoma screening: the Baltimore Eye Survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

7 January 2021

Genetic Risk of Primary Open-angle Glaucoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

7 January 2021

Treatment for glaucoma: adherence by the elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

7 January 2021

Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701746

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6701746

1 reference

PubMed ID

15543179

Dimensions Publication ID

11 August 2017

0 references

1 reference

PubMed ID

15543179